Please login to the form below

Not currently logged in
Email:
Password:

Anders Spohr appointed executive VP for global product supply at Leo Pharma

Former senior VP takes over from John Mehlbye

Leo Pharma has promoted current senior VP Anders Spohr to the position of executive VP for global product supply.

On March 1, 2012, Spohr will take over from John Mehlbye at the Denmark-based pharma firm, with Mehlbye to continue on the board of directors of the Leo Foundation, which owns Leo Pharma.

Spohr only joining Leo Pharma in December, moving from Danish biotech Novozymes where he spent 11 years, serving as vice president of enzymes business supply chain management, production director for Novozymes North America and director of product and technology co-ordination.

Previously, Spohr worked at Novo Nordisk from 1997 to 2000, before Novozymes separated from Novo Nordisk to become its own independent company.

In his new role at Leo, he will have responsibility for ensuring flexible, efficient and streamlined production processes to support the pharma company's operations in more than 100 countries.

28th February 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics